INIS
breasts
100%
cancer
100%
patients
51%
lymph nodes
44%
therapy
42%
biopsy
30%
chemotherapy
28%
reviews
28%
quality of life
26%
safety
23%
surgery
20%
metastases
20%
radiotherapy
20%
risks
19%
women
18%
populations
15%
diseases
14%
receptors
14%
variations
14%
guidelines
10%
humans
7%
growth factors
7%
hormones
7%
netherlands
5%
Keyphrases
Breast Cancer
45%
Neoadjuvant Systemic Therapy
42%
Node-positive Breast Cancer
42%
Axillary Surgery
42%
Registry Study
32%
Dutch
28%
Axillary Staging
25%
Axillary Lymph Node Dissection
24%
Staging Procedures
23%
Less Invasive
23%
Local Radiotherapy
21%
Quality of Life
21%
Oncological Safety
20%
Locoregional Recurrence
19%
Sentinel Lymph Node Biopsy
19%
Recurrence Rate
18%
Mastectomy
14%
Nodal Status
14%
Nationwide Registry
14%
Lymph Node
14%
YpN0
14%
Neoadjuvant Chemotherapy
14%
Positive Sentinel Lymph Node
14%
Prospective Registry
14%
Radiotherapy
14%
Population-based Study
14%
Core Needle Biopsy
14%
Minimax
14%
Targeted Axillary Dissection
14%
Multicenter Registry
14%
Medicine and Dentistry
Breast Cancer
85%
Retroperitoneal Lymph Node Dissection
46%
Systemic Therapy
42%
Axillary Lymph Node
37%
Radiation Therapy
25%
Overall Survival
20%
Recurrence Risk
19%
Sentinel Lymph Node Biopsy
19%
Neoadjuvant Chemotherapy
14%
Lymph Node
14%
Quality of Life
14%
Axillary Surgery
14%
Mastectomy
14%
Systematic Review
14%
Needle Biopsy
14%
Chemotherapy
14%
Disease
12%
Sentinel Lymph Node Metastasis
8%
Epidermal Growth Factor Receptor 2
7%
Gamma Urogastrone
7%
Hormone Receptor
7%
Recurrent Disease
6%
High Risk Population
5%
Axilla
5%
Cancer Registry
5%